Skip to content
Nonprofiteer
← PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC

Form 990 for tax year 2025

Filed by PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC.

Totals

Total revenue
$4,902,599
Total expenses
$5,201,229
Contributions and grants received
$2,829,510
Grants paid
$3,708,833
Program service revenue
$0
Investment income
$2,073,089
Other revenue
$0
Total assets, end of year
$28,801,189
Total liabilities, end of year
$1,517,326
Net assets or fund balances, end of year
$27,283,863
Program services expenses (Part IX)
$4,634,099
Management and general expenses
$563,896
Fundraising expenses
$3,234
Program service expenses (Part III)
$4,634,099

Program services were 89.1% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1a · Federated campaigns

    $0

  • 1b · Membership dues

    $0

  • 1c · Fundraising events

    $0

  • 1d · Related organizations

    $0

  • 1e · Government grants (contributions)

    $0

  • 1f · All other contributions, gifts and grants

    $2,829,510

  • 1g · Noncash contributions included above

    $0

  • 2f · All other program service revenue

    total $0 · related or exempt $0 · unrelated business $0 · excluded $0

  • 3 · Investment income

    total $555,640 · related or exempt $0 · unrelated business $0 · excluded $555,640

  • 6c · Rental income or loss

    real property $0 · personal property $0

  • 7a · Gross sales of assets other than inventory

    securities $8,058,158 · other assets $0

  • 7b · Less cost or other basis and sales expenses

    securities $6,540,709 · other assets $0

  • 7c · Gain or loss

    securities $1,517,449 · other assets $0

  • 7d · Net gain or loss

    total $1,517,449 · related or exempt $0 · unrelated business $0 · excluded $1,517,449

  • 8c · Net income from fundraising events

    total $0

  • 11d · All other revenue

    total $0 · related or exempt $0 · unrelated business $0 · excluded $0

  • 11e · Other revenue, total

    $0

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $0 · program services $0

  • 2 · Grants to domestic individuals

    total $3,698,833 · program services $3,698,833

  • 3 · Grants to foreign organizations and individuals

    total $10,000 · program services $10,000

  • 4 · Benefits paid to or for members

    total $0 · program services $0

  • 5 · Compensation of officers, directors and key employees

    total $613,926 · program services $442,827 · management and general $171,099 · fundraising $0

  • 6 · Compensation of disqualified persons

    total $0 · program services $0 · management and general $0 · fundraising $0

  • 7 · Other salaries and wages

    total $326,105 · program services $235,221 · management and general $90,884 · fundraising $0

  • 8 · Pension plan contributions

    total $70,483 · program services $50,840 · management and general $19,643 · fundraising $0

  • 9 · Other employee benefits

    total $74,207 · program services $53,526 · management and general $20,681 · fundraising $0

  • 10 · Payroll taxes

    total $60,072 · program services $43,330 · management and general $16,742 · fundraising $0

  • 11a · Fees: management

    total $0 · program services $0 · management and general $0 · fundraising $0

  • 11b · Fees: legal

    total $0 · program services $0 · management and general $0 · fundraising $0

  • 11c · Fees: accounting

    total $31,130 · program services $0 · management and general $31,130 · fundraising $0

  • 11d · Fees: lobbying

    total $0 · program services $0 · management and general $0 · fundraising $0

  • 11e · Fees: professional fundraising services

    total $0 · fundraising $0

  • 11f · Fees: investment management

    total $51,244 · program services $0 · management and general $51,244 · fundraising $0

  • 11g · Fees: other

    total $150,570 · program services $34,000 · management and general $116,570 · fundraising $0

  • 12 · Advertising and promotion

    total $9,492 · program services $352 · management and general $9,140 · fundraising $0

  • 13 · Office expenses

    total $1,800 · program services $1,461 · management and general $339 · fundraising $0

  • 14 · Information technology

    total $13,980 · program services $13,681 · management and general $299 · fundraising $0

  • 15 · Royalties

    total $0 · program services $0 · management and general $0 · fundraising $0

  • 16 · Occupancy

    total $0 · program services $0 · management and general $0 · fundraising $0

  • 17 · Travel

    total $16,608 · program services $6,959 · management and general $9,649 · fundraising $0

  • 18 · Travel or entertainment for public officials

    total $0 · program services $0 · management and general $0 · fundraising $0

  • 19 · Conferences, conventions and meetings

    total $15,575 · program services $11,719 · management and general $3,856 · fundraising $0

  • 20 · Interest

    total $0 · program services $0 · management and general $0 · fundraising $0

  • 21 · Payments to affiliates

    total $0 · program services $0 · management and general $0 · fundraising $0

  • 22 · Depreciation, depletion and amortization

    total $32,727 · program services $23,606 · management and general $9,121 · fundraising $0

  • 23 · Insurance

    total $9,651 · program services $6,961 · management and general $2,690 · fundraising $0

  • 24a · Other expenses: Bank/Payroll Charges

    total $9,771 · program services $0 · management and general $9,771 · fundraising $0

  • 24b · Other expenses: Dues/Publications/Projects

    total $5,055 · program services $783 · management and general $1,038 · fundraising $3,234

  • 24e · All other expenses

    total $0 · program services $0 · management and general $0 · fundraising $0

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $2,768,034 · end of year $2,405,817

  • 2 · Savings and temporary cash investments

    beginning of year $0 · end of year $0

  • 3 · Pledges and grants receivable

    beginning of year $0 · end of year $0

  • 4 · Accounts receivable

    beginning of year $0 · end of year $0

  • 5 · Loans and receivables from officers and key people

    beginning of year $0 · end of year $0

  • 6 · Loans and receivables from disqualified persons

    beginning of year $0 · end of year $0

  • 7 · Other notes and loans receivable

    beginning of year $0 · end of year $0

  • 8 · Inventories for sale or use

    beginning of year $0 · end of year $0

  • 9 · Prepaid expenses and deferred charges

    beginning of year $18,563 · end of year $19,527

  • 10a · Land, buildings and equipment: cost or other basis

    $98,178

  • 10b · Land, buildings and equipment: accumulated depreciation

    $70,906

  • 10c · Land, buildings and equipment, net

    beginning of year $59,998 · end of year $27,272

  • 11 · Investments: publicly traded securities

    beginning of year $24,721,524 · end of year $26,348,573

  • 12 · Investments: other securities

    beginning of year $0

  • 13 · Investments: program-related

    beginning of year $0

  • 14 · Intangible assets

    beginning of year $0 · end of year $0

  • 15 · Other assets

    beginning of year $0 · end of year $0

  • 17 · Accounts payable and accrued expenses

    beginning of year $1,517,703 · end of year $1,505,330

  • 18 · Grants payable

    beginning of year $0 · end of year $0

  • 19 · Deferred revenue

    beginning of year $0 · end of year $0

  • 20 · Tax-exempt bond liabilities

    beginning of year $0 · end of year $0

  • 21 · Escrow or custodial account liability

    beginning of year $0 · end of year $0

  • 22 · Loans and payables to officers and key people

    beginning of year $0 · end of year $0

  • 23 · Secured mortgages and notes payable

    beginning of year $0 · end of year $0

  • 24 · Unsecured notes and loans payable

    beginning of year $0 · end of year $0

  • 25 · Other liabilities

    beginning of year $22,982 · end of year $11,996

  • 27 · Net assets without donor restrictions

    beginning of year $26,027,434 · end of year $27,283,863

  • 28 · Net assets with donor restrictions

    beginning of year $0 · end of year $0

Mission and programs · 2025

Mission

THE PHRMA FOUNDATION WORKS TO IMPROVE PUBLIC HEALTH BY PROACTIVELY INVESTING IN INNOVATIVE RESEARCH, EDUCATION AND VALUE-DRIVEN HEALTH CARE.

Activities or mission (Part I)

THE PHRMA FOUNDATION WORKS TO IMPROVE PUBLIC HEALTH BY PROACTIVELY INVESTING IN INNOVATIVE RESEARCH, EDUCATION AND VALUE DRIVEN HEALTH CARE.

  • Drug Discovery - funds early career academic scientists who are pioneering new approaches to drug discovery. We support research projects that have the potential to make a significant impact for patients. By funding the drug discovery research of promising young scientists, the Foundation helps accelerate the identification of new therapeutic compounds and modalities while building a talent base to support innovation across the biopharmaceutical industry.

    Expenses $1,341,859 · Grants $1,085,952

  • Drug Delivery - Funds researchers studying ways to optimize drug composition, dosage, and delivery to make treatments safer, more effective, and easier to manage for patients.

    Expenses $1,055,367 · Grants $856,250

  • Value Assessment-Health Outcomes Research (VA-HOR) - supports early career researchers engaged in a multidisciplinary, collaborative research that investigates challenges and potential solutions related to evaluating the delivery, safe use, effectiveness, and value (clinical, patient-centered, and economic) of medicines and other health care interventions.

    Expenses $901,315 · Grants $739,986

  • Translational Medicine - Funds novel research that uses the "bedside to bench" approach to address unmet needs in the diagnosis, treatment, and prevention of disease. The Foundation supports early career researchers focused on identifying unmet clinical needs and developing new diagnostic, experimental, and computational approaches and technologies to improve patient care and management.

    Expenses $864,045 · Grants $693,309

  • DIGITAL HEALTH TECHNOLOGIES - SUPPORTS RESEARCH ON THE USE OF DHTS IN UNDERREPRESENTED POPULATIONS IN CLINICAL TRIALS TO ADVANCE FDA REGULATORY DECISION MAKING.

    Expenses $410,148 · Grants $333,336

  • Other Program Expenses

    Expenses $61,365

As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Andrew Plump MD PhD

    CHAIRMAN

    Total calculated
    $0
    Hours/week
    1
  • Aida Habtezion MD Msc Frcp

    DIRECTOR (THRU 3/2025)

    Total calculated
    $0
    Hours/week
    1
  • DANIEL SKOVRONSKY MD PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Donatello Crocetta

    Director

    Total calculated
    $0
    Hours/week
    1
  • FIONA H MARSHALL PHD FMedSci FRS

    DIRECTOR (AS OF 6/2025)

    Total calculated
    $0
    Hours/week
    1
  • George Addona PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • JOHN REED MD PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • LORI REILLY Esq

    EX OFFICIO MEMBER

    Total calculated
    $0
    Hours/week
    1
  • Patrizia Cavazzoni MD

    DIRECTOR (AS OF 6/2025)

    Total calculated
    $0
    Hours/week
    1
  • Robert Plenge MD PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Amy Miller

    PRESIDENT

    Total calculated
    $613,926
    From this org
    $535,515
    From related orgs
    $0
    Other
    $78,411
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $369,848
    Bonus
    $163,700
    Other
    $1,967
    Deferred
    $35,000
    Nontaxable benefits
    $43,411
    Filer's total
    $613,926
  • Emily Ortman

    SENIOR DIRECTOR

    Total calculated
    $269,922
    From this org
    $204,960
    From related orgs
    $0
    Other
    $64,962
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $167,806
    Bonus
    $34,136
    Other
    $3,018
    Deferred
    $19,490
    Nontaxable benefits
    $45,472
    Filer's total
    $269,922
  • Joanne Westphal

    DIRECTOR

    Total calculated
    $222,449
    From this org
    $184,732
    From related orgs
    $0
    Other
    $37,717
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $159,922
    Bonus
    $20,675
    Other
    $4,135
    Deferred
    $18,640
    Nontaxable benefits
    $19,077
    Filer's total
    $222,449

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 1a · Health or social club dues or initiation fees
  • 1b · Written policy on the line-1a expenses
  • 2 · Substantiation required before reimbursing expenses
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

Schedule J, Part I, Line 1a Health or social club dues or initiation fees
Health and wellness benefit: All PhRMA Foundation Employees are eligible to participate in the organization's health and wellness benefit up to $1,250 annually. The value of this benefit is considered taxable income.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Provenance

Return type
form_990
Tax year
2025
Filed
17 June 2026
IRS schema version
2025v4.1
Source object
202611689349301046

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.